Seroatlas · Human Serome Atlas

NELFA

Negative elongation factor A

Also known as: NELF-A, NELFA_HUMAN, WHSC2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H3P2
Gene
NELFA
Ensembl
ENSG00000185049
Chromosome
4
Canonical length
528 aa
Protein class
Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nuclear bodies

OverviewNCBI Gene

This gene is expressed ubiquitously with higher levels in fetal than in adult tissues. It encodes a protein sharing 93% sequence identity with the mouse protein. Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4. This gene is mapped to the 165 kb WHS critical region, and may play a role in the phenotype of the WHS or Pitt-Rogers-Danks syndrome. The encoded protein is found to be capable of reacting with HLA-A2-restricted and tumor-specific cytotoxic T lymphocytes, suggesting a target for use in specific immunotherapy for a large number of cancer patients. This protein has also been shown to be a member of the NELF (negative elongation factor) protein complex that participates in the regulation of RNA polymerase II transcription elongation. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

528 residues, UniProt reviewed canonical sequence.

>Q9H3P2|NELFA
     1  MASMRESDTG LWLHNKLGAT DELWAPPSIA SLLTAAVIDN IRLCFHGLSS AVKLKLLLGT
    61  LHLPRRTVDE MKGALMEIIQ LASLDSDPWV LMVADILKSF PDTGSLNLEL EEQNPNVQDI
   121  LGELREKVGE CEASAMLPLE CQYLNKNALT TLAGPLTPPV KHFQLKRKPK SATLRAELLQ
   181  KSTETAQQLK RSAGVPFHAK GRGLLRKMDT TTPLKGIPKQ APFRSPTAPS VFSPTGNRTP
   241  IPPSRTLLRK ERGVKLLDIS ELDMVGAGRE AKRRRKTLDA EVVEKPAKEE TVVENATPDY
   301  AAGLVSTQKL GSLNNEPALP STSYLPSTPS VVPASSYIPS SETPPAPSSR EASRPPEEPS
   361  APSPTLPAQF KQRAPMYNSG LSPATPTPAA PTSPLTPTTP PAVAPTTQTP PVAMVAPQTQ
   421  APAQQQPKKN LSLTREQMFA AQEMFKTANK VTRPEKALIL GFMAGSRENP CQEQGDVIQI
   481  KLSEHTEDLP KADGQGSTTM LVDTVFEMNY ATGQWTRFKK YKPMTNVS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NELFA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
28 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 28 nTPM
  • skin: 26 nTPM
  • ovary: 25 nTPM
  • testis: 24 nTPM
  • cerebellum: 23 nTPM
  • vagina: 22 nTPM

Single-cell type

  • ependymal cells: 223 nCPM
  • sertoli cells: 204 nCPM
  • granulosa cells: 130 nCPM
  • esophageal apical cells: 93 nCPM
  • retinal horizontal cells: 92 nCPM
  • choroid plexus epithelial cells: 89 nCPM

Immune cell

  • naive B-cell: 24 nTPM
  • T-reg: 22 nTPM
  • MAIT T-cell: 19 nTPM
  • memory CD4 T-cell: 18 nTPM
  • plasmacytoid DC: 17 nTPM
  • intermediate monocyte: 17 nTPM

Brain region

  • white matter: 27 nTPM
  • cerebral cortex: 26 nTPM
  • midbrain: 26 nTPM
  • medulla oblongata: 26 nTPM
  • basal ganglia: 25 nTPM
  • spinal cord: 25 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NELFA.

Disease | ImmuneIEDB

Conditions an epitope on NELFA was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.51
gnomAD pLI
0.13
gnomAD missense Z
1.82
DepMap mean gene effect
-0.91
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Hepatitis delta antigen (HDAg) domain
  • Negative elongation factor A domain-containing protein
  • NELF-A, N-terminal domain
  • NELF-A N-terminal domain

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NELFA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NELFA as an antibody target. Whether an autoantibody or antibody against NELFA could matter depends on whether native NELFA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NELFA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NELFA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NELFA. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...